Omni Health Inc (OMHE)

[goodibag]

OMHE_with_CBD_Drug_@FDA_for_Approval_Today_PRd_Received_$7Mln_AntiAging_Cream_Order

OMHE has been rising since its NOV 2017 announcement of CBD Pain medicine development and DEC 2017 update on the initiation of FDA approval process. NOW PUBLISHED THIS FASCINATING $7Million Rev Add news in an already $10Million Rev.

$7Million in Revenue Add News Link

MIAMI, FL, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Omni Health, Inc., (OTC: OMHE), a vertically integrated healthcare company dedicated to the development of pharmaceutical, anti-aging products, and biotech engineering, today announced the launch of its newly-created Consumer Products division commencing with first order from a major US catalog house.

Omni Health’s Consumer Goods Division will be operating via a subsidiary, Celebrity Brands Inc. Celebrity Brands will bring an entirely new reach to Omni Health’s operations with a new set of investment priorities and a sharpened set of portfolio choices to accelerate growth and performance. The company will also focus on strengthening its portfolio by acquiring a number of consumer, revenue-generating brands, and by creating a platform for future acquisitions that scale the distribution of company’s existing brands. The Company anticipates this new division to bring a gross revenue of over $7mln in 2018 with a very high margin EBIDTA.

Celebrity Brands’ first wholesale order is from Amerimark Direct for Celeb Cream – one of the Company’s innovative anti-aging products. Amerimark Direct is one of US largest mail order and direct marketing companies operating ten catalogs and seven websites and specializing in cosmetics, diet and weight loss, personal care products, and As Seen on TV products, among others.

“Omni Health’s new strategic plan establishes a clear set of investment priorities, and the ability to capitalize on company’s four decades of exemplary healthcare by becoming a major force in manufacturing and distributing high-margin anti-aging and CBD consumer brands with the greatest potential for growth and value creation,” said Andrey Soloviev, Omni Health Chief Executive Officer. “We will drive growth acceleration through more effective and scaled commercial operations, increased investment in our brands and capabilities, and the delivery of bigger and better innovation across a broader set of categories.”
With this exciting development, Omni Health intends to become a first mainstream force in the development and introduction to market of innovative CBD and anti-aging consumer products through long-term retail partnerships, high-profile celebrity endorsements, and cross branding.

OMHE is The Champion of 6 Pharmaceutical Industries


Check Their Website

1) Specialty Pharmacy
2) Regenerative Medicine
3) Anti-Aging
4) Skincare Technologies
5) Cannabis Technologies – Another PR is Expected in Few Days!!!
6) Global Wellness

OMHE has scientists, R&D Lab, plan and is ready to market/sell Marijuana based Pain treatment therapeutics and medicine. Also, OTCQB upgrade is on the way!

OMHE_R&D_is_in_Medical_Marijuana_So_Adverse_Recreational_MJ_Laws_Will_Not_Affect_OMHE
And the future of Medical MJ is very bright; Canada is ahead but US scientists will soon become lead researchers!